# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA840340 | A | Fraction absorbed in human intestine after oral administration compound was measured | Homo sapiens | 29 | ALA1145178 | tissue-based format | Scientific Literature | |
2. | ALA851907 | A | Permeability Coefficient in 2/4/A1 cell model | Homo sapiens | 30 | ALA1145178 | cell-based format | Scientific Literature | |
3. | ALA851908 | A | Permeability Coefficient in Caco-2 cell culture model | Homo sapiens | 29 | ALA1145178 | cell-based format | Scientific Literature | |
4. | ALA851909 | A | Permeability Coefficient in hexadecane membranes model | Homo sapiens | 27 | ALA1145178 | cell membrane format | Scientific Literature | |
5. | ALA826140 | A | Percentage of mass balance in hexadecane membranes model | Homo sapiens | 29 | ALA1145178 | cell membrane format | Scientific Literature | |
6. | ALA829539 | B | Inhibitory concentration against [3H]glycylsarcosine uptake in HeLa cells expressing human Intestinal peptide transporter PepT1 | Homo sapiens | 14 | ALA1142674 | cell-based format | Scientific Literature | |
7. | ALA829222 | B | Relative inhibition of [3H]glycylsarcosine uptake in HeLa cells expressing human Intestinal peptide transporter PepT1 compared to BDCRB; na=Not applicable | Homo sapiens | 2 | ALA1142674 | cell-based format | Scientific Literature | |
8. | ALA942581 | A | Cellular uptake in human HeLa cells expressing human PEPT1 transporter after 45 mins | Homo sapiens | 3 | ALA1143268 | cell-based format | Scientific Literature | |
9. | ALA942582 | A | Cellular uptake in human HeLa cells after 45 mins | Homo sapiens | 3 | ALA1143268 | cell-based format | Scientific Literature | |
10. | ALA1006005 | B | Effect on human MRP2-mediated estradiol-17-beta-glucuronide transport in Sf9 cells inverted membrane vesicles relative to control | Homo sapiens | 189 | ALA1150338 | cell-based format | Scientific Literature | |
11. | ALA1034582 | A | Total Cmax in horse at 20 mg/kg, po administered as single dose | Equus caballus | 2 | ALA1151420 | organism-based format | Scientific Literature | |
12. | ALA1034583 | A | fCmax in horse at 20 mg/kg, po administered as single dose | Equus caballus | 2 | ALA1151420 | organism-based format | Scientific Literature | |
13. | ALA1034584 | A | Total Tmax in horse at 20 mg/kg, po administered as single dose | Equus caballus | 2 | ALA1151420 | organism-based format | Scientific Literature | |
14. | ALA1034585 | A | fTmax in horse at 20 mg/kg, po administered as single dose | Equus caballus | 2 | ALA1151420 | organism-based format | Scientific Literature | |
15. | ALA1034586 | A | Total elimination half life in horse at 20 mg/kg, po administered as single dose | Equus caballus | 2 | ALA1151420 | organism-based format | Scientific Literature | |
16. | ALA1034587 | A | Free elimination half life in horse at 20 mg/kg, po administered as single dose | Equus caballus | 2 | ALA1151420 | organism-based format | Scientific Literature | |
17. | ALA1034588 | A | Total AUC in horse at 20 mg/kg, po administered as single dose | Equus caballus | 2 | ALA1151420 | organism-based format | Scientific Literature | |
18. | ALA1034589 | A | fAUC in horse at 20 mg/kg, po administered as single dose | Equus caballus | 2 | ALA1151420 | organism-based format | Scientific Literature | |
19. | ALA1023546 | A | Total oral bioavailability in horse at 20 mg/kg administered as single dose | Equus caballus | 2 | ALA1151420 | organism-based format | Scientific Literature | |
20. | ALA1023547 | A | Free oral bioavailability in horse at 20 mg/kg administered as single dose | Equus caballus | 2 | ALA1151420 | organism-based format | Scientific Literature |